CAM
TAK icon

ClariVest Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

ClariVest Asset Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$658 Hold
51
– – ﹤0.01% 726
2024
Q2 		$658 Sell
51
-4
-7% -$53 ﹤0.01% 726
2024
Q1 		$780 Buy
55
+3
+6% +$44 ﹤0.01% 715
2023
Q4 		$739 Buy
+52
New +$738 ﹤0.01% 730

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

ClariVest Asset Management's TAK Position: Q3 2024 in Review

ClariVest Asset Management held its Takeda Pharmaceutical (TAK) position steady in Q3 2024 at 51 shares worth $658. The position accounts for ﹤0.01% of the portfolio, ranked #726.

ClariVest Asset Management first reported a position in TAK in Q4 2023 and has held it in 4 quarters since. The position peaked at $780 in Q1 2024. 299 funds tracked by Wall St. Rank hold TAK as of Q3 2024.

  • ClariVest Asset Management held 51 shares of Takeda Pharmaceutical worth $658 as of Q3 2024.
  • ClariVest Asset Management left its Takeda Pharmaceutical share count unchanged in Q3 2024.
  • Takeda Pharmaceutical made up ﹤0.01% of ClariVest Asset Management's portfolio in Q3 2024, its #726 holding.
  • ClariVest Asset Management first reported a position in Takeda Pharmaceutical in Q4 2023 and has held it in 4 quarters since.
  • ClariVest Asset Management's Takeda Pharmaceutical position peaked at $780 in Q1 2024.
  • 299 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.